Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014646 |
| CAS No | NA |
| Mol.F. | C11H16N2O4 |
| Mol.Wt. | 240.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014647 |
| CAS No | NA |
| Mol.F. | C18H19N5O2 |
| Mol.Wt. | 337.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014648 |
| CAS No | NA |
| Mol.F. | C9H10N6O4 |
| Mol.Wt. | 266.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014650 |
| CAS No | NA |
| Mol.F. | C25H46N8O12 |
| Mol.Wt. | 650.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014651 |
| CAS No | NA |
| Mol.F. | C12H20N6O3S2 |
| Mol.Wt. | 360.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014652 |
| CAS No | NA |
| Mol.F. | C12H19N7O4S2 |
| Mol.Wt. | 389.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014653 |
| CAS No | NA |
| Mol.F. | C12H20N6O3S2 |
| Mol.Wt. | 360.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014654 |
| CAS No | NA |
| Mol.F. | C21H20N4O4 |
| Mol.Wt. | 392.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014655 |
| CAS No | NA |
| Mol.F. | C16H23N3O2 |
| Mol.Wt. | 289.4 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N014656 |
| CAS No | NA |
| Mol.F. | C27H22N6O5 |
| Mol.Wt. | 510.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014657 |
| CAS No | NA |
| Mol.F. | C17H16N4O2 |
| Mol.Wt. | 308.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014658 |
| CAS No | NA |
| Mol.F. | C13H21N5O4S |
| Mol.Wt. | 343.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014659 |
| CAS No | 185847-75-0 |
| Mol.F. | C13H20N6O5S |
| Mol.Wt. | 372.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014660 |
| CAS No | NA |
| Mol.F. | C13H21N5O4S |
| Mol.Wt. | 343.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014661 |
| CAS No | NA |
| Mol.F. | C12H19N5O7S |
| Mol.Wt. | 377.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014662 |
| CAS No | NA |
| Mol.F. | C23H28N10O3 |
| Mol.Wt. | 492.5 |
| INV STATUS | CUSTOM SYNTHESIS |